Drug intelligence / Profile preview

(2R)-2-amino-3,3,3-trifluoro-N-hydroxy-2-{[(4-phenoxyphenyl)sulfonyl]methyl}propanamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is an experimental small molecule with the chemical formula C16H15F3N2O5S and a molecular weight of approximately 404.36 g/mol. It belongs to the class of organic compounds known as diphenylethers and contains both trifluoromethyl and sulfonamide functional groups. There are no approved indications or clinical trials reported for this compound; it is not approved in the US or elsewhere as a pharmaceutical agent. Its mechanism of action has not been described in public databases and there is no information on its biological targets or pharmacological activity[1][2][3].

Other names
(2R)-2-amino-3,3,3-trifluoro-N-hydroxy-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}propanamide(2R)-2-amino-3,3,3-trifluoro-N-hydroxy-2-[4-(phenoxybenzenesulfonyl)methyl]propanamideIUPAC: (2R)-2-amino-3,3,3-trifluoro-N-hydroxy-2-(4-phénoxyphényl)sulfonylméthylpropanamide[French]

Beyond the preview

Go deeper on (2R)-2-amino-3,3,3-trifluoro-N-hydroxy-2-{[(4-phenoxyphenyl)sulfonyl]methyl}propanamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (2R)-2-amino-3,3,3-trifluoro-N-hydroxy-2-{[(4-phenoxyphenyl)sulfonyl]methyl}propanamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call